[Skip to Navigation]
April 1966

Yeast Vulvovaginitis Due to Oral Contraceptives

Author Affiliations


From the Department of Dermatology (Dr. Porter) and the Department of Obstetrics and Gynecology (Dr. Lyle) Hitchcock Clinic, Hanover, NH and the Department of Obstetrics and Gynecology, Dartmouth Medical School.

Arch Dermatol. 1966;93(4):402-403. doi:10.1001/archderm.1966.01600220014004

Oral contraceptive therapy should be added to the list of those predisposing factors known to enhance yeast growth in the vagina.

Thirteen patients with yeast vulvovaginitis due to oral contraceptive therapy were seen during a six-month period. The potassium hydroxide (KOH) preparation confirmed the diagnosis in 11 of these patients; in selected patients, cultures were necessary. The germ-tube method of identification was rapid and efficient.

Accepted methods for treatment of yeast vulvovaginitis may be only temporarily effective unless the oral contraceptive is discontinued.

Add or change institution